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Protein aggregation is a process in which identical proteins self-associate into imperfectly ordered macroscopic
entities. Such aggregates are generally classified as amorphous, lacking any long-range order, or highly ordered fibrils.
Protein fibrils can be composed of native globular molecules, such as the hemoglobin molecules in sickle-cell fibrils, or
can be reorganized b-sheet–rich aggregates, termed amyloid-like fibrils. Amyloid fibrils are associated with several
pathological conditions in humans, including Alzheimer disease and diabetes type II. We studied the structure of
bacterial inclusion bodies, which have been believed to belong to the amorphous class of aggregates. We demonstrate
that all three in vivo-derived inclusion bodies studied are amyloid-like and comprised of amino-acid sequence-specific
cross-b structure. These findings suggest that inclusion bodies are structured, that amyloid formation is an
omnipresent process both in eukaryotes and prokaryotes, and that amino acid sequences evolve to avoid the amyloid
conformation.
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Introduction
The conversion of peptides and proteins into aggregates is
associated with several dozen pathological conditions in
humans, including Alzheimer disease, Parkinson disease,
and diabetes type II [1–3], and it is also of major concern in
biotechnology [4]. Numerous disease-associated aggregates
are composed of elongated ﬁlaments, termed amyloid-like
ﬁbrils, often comprising intermolecular and in-register b-
sheets parallel to the ﬁbril axis [5–11]. Amyloid ﬁbrils bind
thioﬂavin T (Thio T) [12] and show birefringence upon Congo
red (CR) staining, which is indicative of repetitive structure
[13]. Amyloid ﬁbrils, as highly ordered aggregates, have
traditionally been distinguished from amorphous aggregates,
such as protein precipitates and bacterial inclusion bodies
[14,15]. The latter present widespread problems in biotech-
nology [16].
The deposition of protein products into electron-dense,
apparently amorphous inclusion bodies occurs often during
high-level expression of heterologous and some endogenous
genes in Escherichia coli [17,18]. The aggregation is probably
caused by the high local concentration of nascent polypep-
tides emerging from ribosomes [4], which are ineffectively
protected from aggregation by the insufﬁcient number of
chaperones present during recombinant overexpression, or
by the lack of eukaryotic chaperones [19]. Although inclusion
bodies have been classiﬁed as amorphous aggregates, they are
not just clusters of misfolded proteins that stick to each other
through nonspeciﬁc hydrophobic contacts [14–16]. Rather,
they are often enriched in b-sheet structure [20–22], bind
amyloid-tropic dyes [21], have a seeding capacity reminiscent
of amyloids [21], form homogeneous aggregates without
cross-aggregation [23], and display aggregation propensities
strongly affected by mutations [24]. Here, we studied in detail
the structure of in vivo-derived bacterial inclusion bodies of
three proteins and show that all three inclusion bodies
studied are amyloid-like, comprising amino acid sequence-
speciﬁc cross-b structure.
Results
To elucidate structural details of inclusion bodies of E. coli
(Figures 1–4) and compare them with the structure of
amyloid ﬁbrils, three inclusion body-forming proteins with
distinctive native folds (i.e., b-sheet, a-helix, and mixed a-
helix/b-sheet, with and without disulﬁde bridges) were chosen
to cover the fold universe to a certain degree: (1) The a-
helical, early secreted antigen 6-kDa protein (ESAT-6, with
Protein Data Bank [pdb] accession code 1wa8; Figure 2B)
from Mycobacterium tuberculosis folds only in complex with its
protein partner CFP-10 (culture ﬁltrate protein, 10 kDa) both
in vitro and when overexpressed in E. coli [25]. (2) The mixed
a-helical and b-sheet fragment residues 13–74 of the
secretory human bone morphogenetic protein-2 (BMP2, with
pdb accession code 3bmp) (Figure 3B) [26,27]. BMP2(13–74) is
unable to fold in E. coli because it lacks the essential structural
segment of residues 75–114, as well as the ability to form
disulﬁde links in the cytoplasm of E. coli. (3) The b-sheet
comprising the extracellular domain (ECD) of the human
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PLoS BIOLOGYmembrane protein myelin oligodendrocyte glycoprotein
(MOG(ECD), with pdb accession code 1pko), having one
disulﬁde bridge (Figure 4B) [28,29]. The inclusion body
formation of MOG is attributed to the reducing environment
of the E. coli cytoplasm.
Inclusion Bodies of ESAT-6 Are Composed of Ordered b-
Sheet Structure
All three proteins studied are present in the insoluble
fraction of E. coli upon overexpression (Figures 2E, 3E, and
4E) and form homogeneous inclusion bodies as expected
(unpublished data). The puriﬁed inclusion bodies of all three
proteins bind Thio T to a similar or greater extent than aged
amyloid ﬁbrils of a-synuclein (Figure 1) and produce strong
birefringence upon CR staining (Figures 1 and S1). These
ﬁndings indicate that inclusion bodies of all three proteins
studied comprise highly ordered structures reminiscent of
amyloid-like ﬁbrils.
We found, furthermore, that inclusion bodies of all three
proteins contain sequence-speciﬁc positions of regular
secondary structure, by measuring quenched hydrogen/
deuterium (H/D) exchange with solution nuclear magnetic
resonance (NMR) [9,30] (see also Materials and Methods). This
technique allows the identiﬁcation of solvent-protected
backbone amide protons involved in hydrogen bonds. In
the case of ESAT-6, the [
15N,
1H]-correlation NMR spectrum
of Figure 2A (left) contains one assigned cross peak for
approximately 90% of all its backbone amides, enabling a
residue-speciﬁc determination of their hydrogen exchange
rates in inclusion bodies. Upon exchange in D2O buffer for
311 h (Figure 2A, right), many cross peaks show a virtually
complete loss of intensity, which is indicative of fast
exchange. In contrast, a set of cross peaks of residues 8–25
and 36–43 are still present, which is indicative of slow
exchange. The hydrogen exchange was followed over time to
get insight into conformational heterogeneity (Figure S2).
Individual amides of all residues display a biphasic behavior
comprising a very fast and a slow exchanging component
(Figure S2). However, for most of the residues, only either the
fast or the slow exchanging component is highly populated
(Figure 2C; P . 2/3, where P is the population).
The detailed sequence-resolved analysis of the hydrogen
exchange data of the major population (Figure 2C) shows
that, most of the residues (i.e., 2–6, and 24–95) are only
weakly or not protected and are therefore considered to be
conformationally disordered. This is indicated by exchange
rates faster than 10
1 h
 1. In contrast, residues 7–23 display
slow exchange rates of 10
 3 to 10
 4 h
 1 and are therefore
considered to be involved in hydrogen bonds (Figure 2C).
Because the circular dichroism (CD) spectrum is indicative of
b-sheet and ‘‘random coil’’ conformation (Figure S3), it is
likely that the solvent-protected residues 7–23 contain mainly
b-sheet secondary structure. The presence of abundant b-
structure is strongly supported by the ﬁber diffraction data
of inclusion bodies of ESAT-6 (Figure 2D). The sharp
reﬂection observed at 4.7 A ˚ is interpreted as the spacing
between strands in a b-sheet. The diffuse reﬂection at
approximately 10 A ˚ is interpreted as the spacing between
b-sheets. These two reﬂections are typically observed for
amyloid-like ﬁbrils. The circular proﬁles for these reﬂections,
rather than orthogonal positions for the two reﬂections,
show that the directions of the amyloid-like entities in
inclusion bodies are not strongly aligned. To conﬁrm the
potential of residues 7–23 to be in a cross-b-sheet amyloid
conformation, a synthetic peptide E20 corresponding to
residues 6–25 of ESAT-6 was tested for in vitro aggregation.
Figure 1. Amyloid-Like Character of Three Bacterial Inclusion Bodies
CR birefringence and Thio T binding of inclusion bodies are indicative of
amyloid formation. Under cross-polarized light with 103 magnification,
CR birefringence is observed for BMP2(13–74), ESAT-6, and MOG(ECD).
Larger images together with the corresponding pictures from the bright-
field microscope are shown in Figure S1. The histogram shows the
relative Thio T binding of BMP2(13–74), ESAT-6, and MOG(ECD) in
comparison to aged a-synuclein (a-Syn) fibrils. The intensity of the Thio T
fluorescence is shown in arbitrary units (AU).
doi:10.1371/journal.pbio.0060195.g001
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Author Summary
Protein aggregation is a process by which identical proteins self-
associate into imperfectly ordered macroscopic entities. Such
aggregates are associated with several pathological conditions in
humans, including Alzheimer disease, Parkinson disease, and
diabetes type II. Furthermore, protein aggregation is a major
concern in the biotechnological production of recombinant proteins
and the storage of proteins, and is a central mechanism of protein
folding. In general, two classes of protein aggregates are classified:
first, highly ordered aggregates can be composed of native globular
molecules, such as the hemoglobin molecules in sickle-cell fibrils, or
reorganized into b-sheet–rich aggregates, termed amyloid-like
fibrils; and second, amorphous aggregates that lack any long-range
order. Here, we demonstrate that bacterial inclusion bodies, which
have been believed to be made up of amorphous aggregates, are in
fact amyloid-like, comprising cross-b structure that is dependent on
amino-acid sequence. These findings suggest that inclusion bodies
are structured, that amyloid formation is a process present in both
eukaryotes and prokaryotes, that amino acid sequences can evolve
to avoid the amyloid conformation, and that there might be no
amorphous state of a protein aggregate.Figure 2. The Short Segment of Residues 7–23 of ESAT-6 Forms Cross-b-Sheet Structure in Inclusion Bodies of E. coli
(A) Fast [
15N,
1H]-HMQC spectra of dissolved, monomeric
15N-labeled ESAT-6 in d6-DMSO containing 0.05 % TFA and 25 mM DTT, corresponding to fully
protonated inclusion bodies (left), and to inclusion bodies exchanged for 311 h in D2O (right). After 311 h, many cross peaks show a complete loss of
intensity indicative of fast exchange. In contrast, cross peaks of residues 8–25 and 36–43 are still present, indicative of slow exchange. Sequence-specific
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Inclusion Bodies Are Amyloid-LikeUpon incubation for 3 d at physiological conditions, E20
forms amyloid ﬁbrils as evidenced both by electron micro-
scopy (EM) (Figure S5) and Thio T binding (unpublished
data).
To verify that the cross-b-sheet–forming segment of
residues 7–23 is the dominant component in the formation
of inclusion bodies of ESAT-6, the following mutagenesis
experiments were carried out: Within the sequence of ESAT-
6, aggregation-prone hydrophobic residues were replaced by
the aggregation-interfering Arg [31]. The substitution of
L36R, V54R, or I76R did not alter substantially the formation
of inclusion bodies. This ﬁnding is expected because these
residues are located within the disordered region of the
inclusion bodies. In contrast, the substitution of F8R, I11R,
I18R, or V22R within the b-sheet–forming segment abolished
the formation of inclusion bodies (Figure 2E). Similarly, the
deletion of the cross-b-sheet–forming segment of residues 7–
23 or its replacement by a non–aggregation-prone segment of
residues 25–41 of ESAT-6, which forms a helix in the soluble
structure of ESAT-6, resulted both in a loss of inclusion body
formation (Figure 2E). The lack of soluble expressed ESAT-6
variants comprising the latter substitutions and deletions is
attributed to their fast degradation [15]. To conﬁrm that the
plasmids of the latter point mutants were functionally
conserved, they were mutated back to wild type, which
restored the formation of inclusion bodies upon over-
expression (Figure S4). Consistent with all our ﬁndings, one
of the two applied algorithms that predict aggregation-prone
segments [32,33] indicates residues approximately 7–23 to be
the most-aggregation-prone segment of ESAT-6 (Figure 2C).
In summary, residues 7–23 of ESAT-6 in bacterial inclusion
bodies form a cross-b-sheet structure characteristic of
amyloid-like ﬁbrils [5,10] with the remainder of the amino
acid sequence disordered.
Two Other Inclusion Bodies Also Contain Ordered b-Sheet
Structure
Very similar ﬁndings are observed for inclusion bodies of
BMP2(13–74) and MOG(ECD). Upon exchange in D2O buffer
for 185 and 285 h, respectively, many cross peaks of the
[
15N,
1H]-correlation spectra show a virtually complete loss of
intensity, which is indicative of fast exchange (Figures 3A and
4A). In contrast, a set of cross peaks of residues 62–70 of
BMP2(13–74) and most of the residues 80–94, 102–105, and
110–117 of MOG(ECD), respectively, are still present, which is
indicative of slow exchange. Again, the H/D exchange of all
residues displayed a biphasic behavior with a very fast and
slow exchanging component (Figures 3C, 4C, and S2). The
hydrogen exchange data of the major population of inclusion
bodies show that residues 14–61 and 68–74 of BMP2(13–74)
(Figure 3C), and residues 2–84, 96–100, 109–110, and 119–133
of MOG(ECD) (Figure 4C) are not protected or only weakly
protected and may therefore be conformationally disordered.
In contrast, residues 62–67 of BMP2(13–74) (Figure 3C) and
residues 85–95, 101–108, and 111–118 of MOG(ECD) (Figure
4C) display slow exchange rates of 10
 2 to 10
 4 h
 1 and are
therefore considered to be involved in hydrogen bonds. Since
diffraction patterns of both inclusion bodies are indicative of
cross-b structure (Figures 3D and 4D), it is likely that the
solvent-protected segments contain mainly b-sheet secondary
structure of cross-b-sheet nature. These ﬁndings are further
conﬁrmed by the amyloid-like ﬁbril formation of synthetic
peptides B13 corresponding to residues 59–71 of BMP2(13–
74), and M11 and M18 corresponding to residues 85–95 and
101–118 of MOG(ECD) (Figure S5). Consistent with these
data, the combination of the applied algorithms that predict
aggregation-prone segments [32,33] indicate residues approx-
imately 62–67 and residues approximately 100–118 to be the
most aggregation-prone segments of BMP2(13–74) (Figure
3C) and MOG(ECD) (Figure 4C).
A similar mutagenesis experiment as described above was
carried out to verify that the cross-b–forming segment
residues 62–67 of BMP2(13–74) and the segments 85–95,
101–108, and 111–118 of MOG(ECD) are the dominant
components in the formation of inclusion bodies (Figures
3E and 4E). As expected, the substitutions I32R and L51R of
BMP2(13–74) did not alter the formation of inclusion bodies,
because the substitutions are located within the disordered
segment of the inclusion bodies. In contrast, the substitutions
I62R, V63G, V63E, V63R, and L66R of BMP2(13–74) within
the b-sheet–forming segment abolished or diminished the
formation of inclusion bodies (Figure 3E). Moreover, these
variants are present in the soluble fraction of the E. coli lysate
upon overexpression (Figure 3E). In particular, the replace-
chemical-shift assignment of protein backbone amide cross peaks are indicated by a single-letter amino acid code and the corresponding residue
number.
(B) Ribbon representation of the 3-D structure of soluble ESAT-6 in complex with CFP-10 [25]. The green-colored segment corresponds to residues 7–23,
which experiences slow exchange in inclusion bodies as shown in (C).
(C) Plots of the observed exchange rates kex/h, the relative population P(F) of the two exchange regimes observed with P¼1 for 100% occupancy and P
¼0 for 0% occupancy, and the predictions of aggregation-prone segments against the amino acid sequence of ESAT-6. The exchange rates of the major
population are colored green. If the minor population is present more than 1/3, the corresponding exchange rates are shown in grey. Although some of
the residues 36–43 show slow exchange in the HMQC spectrum in (A), their slow-exchanging population is present less than 1/3 and hence not shown
in (C). In the third plot of (C) labeled with an ‘‘A,’’ predicted aggregation-prone segments of ESAT-6 are shown using two distinct algorithms: 3DPROFILE
[33] in gray, and TANGO [32] (the latter is not shown, since no aggregation-prone segment was predicted). For 3DPROFILE, predictions are shown for
segments having energies    23 kcal/mol. For both algorithms, outstanding relative values (   23 in 3DPROFILE, and .0 in TANGO) within a segment
of several amino acid residues are indicative of an aggregation-prone segment. The secondary structures of the soluble conformation shown in (B) are
highlighted in red for helix and blue for b-sheet, respectively. The secondary structural elements predicted by the software Jpred [53] are highlighted by
cyan arrows for b-sheet conformation and a yellow helix for helical structure, respectively. An amino-acid sequence-resolved hydrophobicity score plot
calculated by the software ProtScale [54,55] is shown at the lowest panel labeled with ‘‘H,’’ with positive values indicative of hydrophobicity.
(D) X-ray diffraction of inclusion bodies of ESAT-6. The two reflections at 4.7 A ˚ and approximately 10 A ˚ consistent with cross-b-sheet structure are
labeled.
(E) Mutagenesis of ESAT-6 and the influence of amino acid substitutions in the formation of inclusion bodies. Coomassie-stained SDS-polyacrylamide
gels were obtained from soluble (s) and insoluble (i) fractions of lysates of E. coli cells expressing wild-type ESAT-6 (WT) or ESAT-6 variants as indicated
(i.e., point mutations are indicated by a one-letter code, D7–23 stands for the deletion variant, which lacks the slow-exchanging residues 7–23, and
‘‘replaced’’ stands for the mutant for which residues 7–23 were replaced with the helical segment of residues 25–41 of ESAT-6. The 10-kDa molecular
weight standard is labeled. The variants that are present in the insoluble fraction are colored blue in the amino acid sequence of (C), and the single
amino acid residue variants that are absent in the insoluble fractions are colored red in the amino acid sequence of (C), respectively.
doi:10.1371/journal.pbio.0060195.g002
PLoS Biology | www.plosbiology.org August 2008 | Volume 6 | Issue 8 | e195 1794
Inclusion Bodies Are Amyloid-LikeFigure 3. The Short Segment of Residues 62–67 of BMP2(13–74) Forms Cross-b Structure in Inclusion Bodies of E. coli
(A) Fast [
15N,
1H]-HMQC spectra of homogenously
15N-labeled monomeric BMP2(13–74) in d6-DMSO containing 0.05 % TFA and 25 mM DTT,
corresponding to fully protonated inclusion bodies (left), and to inclusion bodies that exchanged for 185 h in D2O (right). After 185 h, many cross peaks
show a complete loss of intensity, indicative of fast exchange. In contrast, cross peaks of residues 62–70 are still present, indicative of slow exchange.
(B) Ribbon representation of the 3-D structure of soluble BMP2. The green-colored segment corresponds to residues 62–67 that comprise slow
exchange in inclusion bodies as shown in (A) and (C). The protein fragment BMP2(13–74) comprising residues 13–74 is highlighted in grey. The N-
terminal 12 residues and the C-terminal 40 residues of BMP2 are colored black.
(C) Plots of the observed exchange rates kex/h, the relative population P(F) of the two exchange regimes observed (Figure S2), and the predictions of
aggregation-prone segments against the amino acid sequence of BMP2(13–74). The exchange rates of the major population are colored green. If the
minor population is present more than 1/3, the corresponding exchange rates are shown in grey. In the third plot of (C) labeled with ‘‘A,’’ predicted
aggregation-prone segments of BMP2(13–74) are shown using two algorithms: 3DPROFILE [33] in gray and TANGO [32] in blue. Predictions of
aggregation are shown for segments having energies    23 kcal/mol from 3DPROFILE, and values .0 from TANGO. The secondary structures of the
soluble conformation shown in (B) are highlighted in red for helix and blue for b-sheet, respectively. The secondary structural elements predicted by the
software Jpred [53] are highlighted by cyan arrows for b-sheet conformation and a yellow helix for helical structure, respectively. An amino acid
sequence-resolved hydrophobicity score plot calculated by the software ProtScale [54,55] is shown at the bottom, labeled with ‘‘H,’’ with positive
values indicative of hydrophobicity.
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Inclusion Bodies Are Amyloid-Likement series at position 63 indicate that all kinds of
aggregation-interfering residues [31] (i.e., with or without
charge, small or large side chains, positive or negative
charged) are able to perturb inclusion body formation, which
results in the presence of soluble protein (Figure 3E).
To further strengthen the ﬁnding that the hydrogen-
protected residues 62–67 of BMP2(13–74) are responsible for
the formation of inclusion bodies, a plasmid was constructed
that codes for residues 61–70 of BMP2(13–74) C-terminally to
the protein domain PDZ1 of SAP90, which alone is expressed
highly soluble in E. coli (Figure S6). Since the BMP2-tag,
denoted as B10, is highly aggregation prone, upon over-
expression in E. coli, the fusion protein PDZ1-B10 is present
mainly as inclusion bodies (Figure S6). Hence, the hydrogen-
protected residues 62–67 appear to be the dominant
components in the formation of inclusion bodies.
In the mutagenesis experiment of MOG(ECD), substitu-
tions within the disordered segments did not alter the
formation of inclusion bodies, as expected. However, single
point substitutions within one b-sheet–forming segment are
not sufﬁcient to abolish inclusion body formation, indicating
that the presence of one aggregation-prone segment of b-
sheet secondary structure is sufﬁcient for inclusion body
formation (Figure 4E). Diminished inclusion body formation
is observed only with the deletion variants MOG(1–73) and
MOG(1–83) which lack all the hydrogen exchange-protected
segments (Figure 4E).
In summary, in bacterial inclusion bodies of BMP2(13–74)
and MOG(ECD), residues 62–67 of BMP2(13–74) and residues
85–95, 101–108, and 111–118 of MOG(ECD) form cross-b–
structure characteristic of amyloid-like ﬁbrils, whereas the
remainder of the amino acid sequence is disordered.
Inclusion Bodies May Contain Amyloid-Like Protofibrils
Although the inclusion bodies studied here are amyloid-
like, they do not display ﬁbrils under EM (Figure 5A). The
absence of visible ﬁbrils may be attributed to the high protein
concentration in inclusion bodies and to the abundant,
stained amorphous segments of the protein (Figures 2, 3, and
4) obscuring the ﬁbrils. An alternative explanation could be
that inclusion bodies form too rapidly for ﬁbrils to form from
the more immature and ﬂexible protoﬁbrils that have less
rigidly linear proﬁles (see also below). We favor this latter
hypothesis because of the following reasons: Varying the
amount or time of staining as well as grinding inclusion
bodies or treating inclusion bodies with chemical denaturant
did not reveal reproducible and signiﬁcant ﬁbril formation
under EM (unpublished data). In contrast, upon incubation of
puriﬁed inclusion bodies of BMP2(13–74) at 37 8C for 12 h,
ﬁbrils appear and grow more prominent with time (Figure
5B).The qualitative analysis of EM shows thereby two
scenarios: (1) the ﬁbrils appear to grow from the inclusion
bodies (Figure 5A), and (2) the inclusion bodies comprise
highly dense bundles of amyloid ﬁbrils (Figure 5B). The
apparent growth of ﬁbrils from inclusion bodies can be
accelerated by higher temperature (tested up to 50 8C;
unpublished data), but is not present in a sample stored for
10 mo at 4 8C (unpublished data). Furthermore, protein
overexpression of BMP2(13–74) in E. coli over a period of 12 h
under semi-controlled physiological conditions yields inclu-
sion bodies with ﬁbril-like structural entities (Figure 5C).
Similarly, upon incubation of puriﬁed inclusion bodies of
ESAT-6 at room temperature (;21 8C) for 14 d, amyloid-like
ﬁbrils appear under EM (Figure S7). We therefore suggest
that inclusion bodies are reminiscent of amyloidogenic
protoﬁbrils.
Discussion
Common Structural Properties of Inclusion Bodies
Our structural studies of three bacterial inclusion bodies
reveal the presence of distinct sequence-speciﬁc cross-b-sheet
structures surrounded by amorphous disordered segments.
The number of cross-b segments is variable (i.e., one to three
b-segments in the three proteins studied here). Their lengths
are typically around seven to ten residues long, if it assumed
that the 16-residue-long solvent-protected segment of ESAT-
6 inclusion bodies may be interrupted in the middle. The b-
strands in inclusion bodies do not necessary have a b-sheet
conformation in the corresponding soluble fold of the
protein (Figures 2B, 3B, and 4B). In particular, the segments
comprising a b-sheet structure in the inclusion bodies of
ESAT-6 and BMP2(13–74) are helical in the corresponding
soluble folded conformations (Figures 2B and 3B). However,
although the amino acid sequence composition of the various
b-strands involved in aggregation are quite heterogeneous,
these segments share common properties when compared
with nonaggregating sequences. First, they display a low
energy when complementing themselves in a pair of b-sheets,
as required by the 3DPROFILE algorithm [33], and second,
they have a high propensity to form a b-aggregate, as required
by the TANGO algorithm [32]. Neither algorithm makes
predictions in perfect agreement with the NMR results, but
the agreement is good considering that the energy models of
the two algorithms are entirely different (Figures 2C, 3C, and
4C).
Hence, in striking contrast to the traditional view of
bacterial inclusion bodies as amorphous aggregates, they may
contain ordered structural segments of cross-b structure, of
which the number, length, and form of its b-sheets are
determined by the particular amino acid sequence of the
protein. The structures of these regions are thereby probably
restricted to one of the possible topologies of cross-b
structures [10]. Adjacent to the cross-b-sheet core of the
inclusion body aggregates, there may be amorphously
disordered segments (Figures 2, 3, and 4), or also folded
domains [34,35].
Evolutionary Pressure against Amyloid Aggregates
Under the assumption that the observed amyloid-like
nature of inclusion bodies (Figures 1–4 and [21]) holds for
most of the hundreds of documented bacterial inclusion
bodies [36], amyloid aggregation appears to be a common
(D) X-ray diffraction of inclusion bodies of BMP2(13–74), indicative of cross-b-sheet structure.
(E) Mutagenesis of BMP2(13–74). Coomassie-stained SDS-polyacrylamide gels were obtained from soluble (s) and insoluble (i) fractions of lysates of E.
coli cells expressing wild-type BMP2(13–74) (WT) or variants as indicated. The identities of the bands were verified by mass spectrometry analysis (see
Material and Methods). The 6-kDa molecular weight standard is labeled. The same nomenclature, labeling, and layout are used as in Figure 2.
doi:10.1371/journal.pbio.0060195.g003
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Inclusion Bodies Are Amyloid-LikeFigure 4. The Segments of Residues 85–95, 101–108, and 111–118 of MOG(ECD) Form a Cross-b-Sheet Structure in Inclusion Bodies of E. coli.
(A) Fast [
15N,
1H]-HMQC spectra of homogenously
15N-labeled monomeric MOG(ECD) in d6-DMSO containing 0.05 % TFA and 25 mM DTT, corresponding
to fully protonated inclusion bodies (left), and to inclusion bodies that exchanged for 285 h in D2O (right). After 285 h, many cross peaks show a virtually
PLoS Biology | www.plosbiology.org August 2008 | Volume 6 | Issue 8 | e195 1797
Inclusion Bodies Are Amyloid-Likeproperty of protein segments and consequently is observed in
both eukaryotes and prokaryotes [2]. Within the framework
of this hypothesis, it has been suggested that there must be
evolved strategies against amyloid formation, which include
both quality control mechanisms through molecular chaper-
ones as well as sequence-based prevention of amyloid
aggregation [31,32,37,38]. The suggested evolutionary pres-
sure on the protein’s amino acid sequence composition
against amyloid-like aggregation is evident from our present
inclusion body study. The amino acid sequence of over 80%
of ESAT-6, 90% of BMP2(13–74), and approximately 75% of
MOG(ECD) are disordered in inclusion bodies (Figures 2C,
3C, and 4C) and hence not aggregation prone. This ﬁnding
indicates that the majority of residues in the amino acid
sequences of all three proteins studied have evolved to
disfavor aggregation.
Bacterial Inclusion Bodies and Human Amyloid Diseases
The formation of amyloid-like inclusion bodies of E. coli
may also provide insights into fundamental mechanisms of
amyloid aggregation-related pathologies such as Alzheimer
disease and prion diseases [17]. In these so-called amyloid
diseases, a soluble protein or peptide alters its state via
conformational intermediates into amyloid ﬁbrils [1]. Some
of the intermediates, rather than the amyloid ﬁbrils them-
selves, have been proposed to be the most toxic amyloid
entities [2,39]. These intermediates might include protoﬁ-
brils. The data presented here and by others suggest that
inclusion bodies exhibit structural and some biological
properties of protoﬁbrillar amyloid aggregates [40,41] in that
inclusion bodies are amyloid-like in structure, are able to
mature into amyloid-like ﬁbrils with time (Figure 5), and show
amyloid-like ‘‘cytotoxicity’’ when administered to an eukary-
otic cell line [42]. Furthermore, we show in Figure S8, that the
amyloidogenic mouse prion protein and fragments thereof
form amyloid-like inclusion bodies when expressed in E. coli.
Despite the similar biological and structural properties of
inclusion bodies and protoﬁbrils or ﬁbrils associated with
pathological conditions, inclusion bodies are not toxic to its
host E. coli and are believed rather to be a detoxiﬁcation
mechanism [43]. The lack of toxicity of inclusion bodies is in
agreement with the lack of toxicity of amyloid b-protein (Ab)
amyloids and other amyloid ﬁbrils when administered to a
dermal cell line [44]. These ﬁndings may support the
hypothesis that the toxic species in amyloid diseases is a
small oligomer rather than the amyloid ﬁbrils [45–47].
Our studies suggest a tight structural link between amyloid
aggregates associated with human amyloid diseases, inclusion
bodies of the aggresome [48], and inclusion body formation
in E. coli. In addition, these structural studies of bacterial
inclusion bodies extend the possible structural landscape of
every protein: each protein may exist, not only in an unfolded
or folded state, but, by containing at least one amino acid
segment that is capable of participating in a sequence-
speciﬁc, ordered, cross-b-sheet aggregated state, may also
exist in an amyloid-like aggregate. The process of protein
aggregation can thus be viewed as a primitive folding
mechanism, resulting in a deﬁned, aggregated conformation
with each aggregated protein having its own distinctive
properties.
Materials and Methods
Cloning and expression of proteins and variants thereof. The
plasmids of ESAT-6 (M. tuberculosis) is a kind gift of Dr. Jeffery S. Cox
(University of California, San Francisco), the plasmid of BMP2
(human) is a kind gift of Dr. Senyon Choe (Salk Institute), and the
plasmid of MOG (rat) is a kind gift of Dr. Nancy Ruddle (Yale
University) and Dr. Christopher Linington (University of Aberdeen).
The DNAs encoding the ESAT-6 and BMP2(13–74) were cloned into
the pET21a(þ) vector. The DNA encoding the extracellular domain of
MOG (MOG(ECD)) was cloned into the pQE-12 vector with and
without a C-terminal His-tag [28]. All the experiments throughout
this work was done with His-tagged MOG(ECD), since both His-
tagged and His-tag–free MOG(ECD) form inclusion bodies with a very
similar H/D exchange pattern (unpublished data). All site-directed
mutants were generated with the appropriate nucleotide modiﬁca-
tion by PCR and sequenced for accuracy. All proteins were grown in
BL21(DE3) cells at 37 8C, and were induced at optical density at 600
nm (OD600) ¼ 1.0 for 3 h by addition of 1 mM isopropyl b-D-
thiogalactoside. The isotopically enriched (
15N/
13C) samples were
prepared by growing cells in M9 medium containing
15NH4Cl/ [
13C]
glucose. For the overexpression of BMP2(13–74) over a time of 12 h,
the pH of the medium was adjusted every 4 h.
Inclusion body preparation. The cells from each 500 ml of medium
were harvested by centrifugation, resuspended in 20 ml of buffer A
(10 mM Tris, 1 mM EDTA, 25 mM dithiothreitol [DTT] [pH 7.5]), and
lysed by sonication on ice (5 min 3 2, 50% amplitude, Sonic
Dismembrator Model 500, Fisher Scientiﬁc). Inclusion bodies were
sedimented by centrifugation at 10,000g for 10 min at 4 8C, and
complete loss of intensity, indicative of fast exchange. In contrast, a set of cross peaks labeled by their corresponding amino acid residue number are
still present, indicative of slow exchange.
(B) Ribbon representation of the 3-D structure of soluble MOG(ECD) [28]. The green-colored segments correspond to residues 85–95, 101–108, and 111–
118, which comprise slow exchange in inclusion bodies as shown in (C).
(C) Plots of the observed exchange rates kex/h, the relative population P(F) of the two exchange regimes observed, and the predictions of aggregation-
prone segments against the amino acid sequence of MOG(ECD). The exchange rates of the major population are colored green. If the minor population
is present more than 1/3, the corresponding exchange rates are shown in grey. Because of the size of the protein, considerable overlap is observed in
the DMSO spectrum (see [A]), making the analysis of the exchange rates of some residues difficult. However, most of these overlap problems could be
resolved by the assumption that sequential neighboring residues show a similar extent of exchange. The exchange rates that have been extracted
following this procedure are colored in light green. In the third plot of (C), predicted aggregation-prone segments of MOG(ECD) are shown using two
algorithms: 3DPROFILE [33] in gray and TANGO [32] in blue. Predictions of aggregation are shown for segments having energies    19.5 kcal/mol from
3DPROFILE, and values .0 from TANGO. The secondary structures of the soluble conformation shown in (B) are highlighted in red for helix and blue for
b-sheet, respectively. The secondary structural elements predicted by the software Jpred [53] are highlighted by cyan arrows for b-sheet conformation
and a yellow helix for helical structure, respectively. An amino acid sequence-resolved hydrophobicity score plot calculated by the software ProtScale
[54,55] is shown at the bottom labeled with ‘‘‘H,’’ with positive values indicative of hydrophobicity.
(D) X-ray diffraction of inclusion bodies of MOG(ECD). The two observed bands at 4.7 A ˚ and approximately 10 A ˚ indicative of cross-b-sheet structure are
labeled.
(E) Mutagenesis of MOG(ECD) and the influence of amino acid substitutions in the formation of inclusion bodies. Coomassie-stained SDS-
polyacrylamide gels were obtained from soluble (s) and insoluble (i) fractions of lysates of E. coli cells expressing wild-type MOG(ECD) (WT) or variants as
indicated. The 15-kDa molecular weight standard is labeled. The variants that are present in the insoluble fraction are colored blue in the amino acid
sequence of (C). The same nomenclature, labeling, and layout are used as in Figure 2.
doi:10.1371/journal.pbio.0060195.g004
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Inclusion Bodies Are Amyloid-Likewashed three times with the same buffer. See Figure S9 highlighting
the individual steps of the puriﬁcation protocol.
Thioﬂavin T binding. Inclusion body sample was diluted in 500 ll
of buffer A to a ﬁnal concentration of 20 lM. The solution was mixed
with 5 ll of 2 mM Thio T prepared in the same buffer. Fluorescence
was measured immediately after addition of Thio T. The experiment
was measured on a spectroﬂuorimeter (Photon Technology Interna-
tional) with excitation at 450 nm and emission at 485 nm. A
rectangular 10-mm quartz microcuvette was used. As reference, a-
synuclein ﬁbrils were measured as follows: a 14-ll aliquot of aged a-
synuclein sample (10 mg/ml protein, PBS [pH 7.4]) was diluted in 500
ll of buffer A to a ﬁnal concentration of 20 lM. The solution was
mixed with 5 ll of 2 mM Thio T prepared in the same buffer.
Congo Red birefringence. The CR staining was performed using
the diagnostic amyloidal stain kit HT60 from Sigma. Brieﬂy, puriﬁed
inclusion bodies in buffer A were pelleted by centrifuge at 16,000g
and washed once by distilled water. The inclusion bodies were then
placed in 500 ll of alkaline sodium chloride solution for 20 min, with
continuous vortexing. The continuous vortexing enhances the uni-
form mixing of all inclusion bodies particles in solution. The mixture
was then centrifuged brieﬂy with 16,000g, and pellets were taken to
stain with alkaline CR solution for 20 min, with continuous vortexing.
The mixtures were centrifuged brieﬂy at 16.000g, and pellets were
washed twice with 500 ll of 20% ethanol. The pellets were
resuspended in PBS and then spread evenly onto glass slides and
air dried at room temperature. The slides were analyzed using a
microscope equipped with two polarizers equipped with a charge-
coupled device (CCD) camera.
Sequential NMR assignment. Nearly complete sequence-speciﬁc
assignment of the backbone H
N/N cross peaks in the [
15N,
1H]-HMQC
spectra were obtained for all three proteins using the triple-
resonance experiments HNCACB [49] and (H)N(COCA)NH [50]
applied to
13C,
15N-labeled inclusion bodies solubilized in dimethyl
sulfoxide-d6 (d6-DMSO) containing 0.05% triﬂuoroacetic acid (TFA)
and 25 mM DTT.
H/D exchange. Homogenously
15N-labeled inclusion bodies of
BMP2 (13–74), ESAT-6, and MOG(ECD) were used for the H/D-
exchange studies. To start the H/D exchange, the inclusion bodies
solution (0.5 ml, 200 lM) was centrifuged at 13 000g for 3 min, the
separated inclusion bodies pellet was washed with D2O twice, then
resuspended in 0.5 ml of D2O and kept at 4 8C for H/D exchange.
Right before each NMR measurement, the H/D-exchanged inclusion
bodies were sedimented at 13,000g for 3 min and dissolved in d6-
DMSO containing 0.05% TFA and 25 mM DTT. Immediately after
dissolving the inclusion bodies, the [
15N,
1H]-correlation spectra
(HMQC) were measured for 5 min. Residues that display high
intrinsic exchange rates in DMSO were determined by the addition of
H2O followed by the measurement of a series of 2-D spectra. Using
this control measurement, some residues were excluded from the H/
D-exchange data analysis. To conﬁrm that during the H/D-exchange
measurement the inclusion bodies were preserved in their structural
properties, EM and Thio T binding studies were performed at day 0
and day 15 (Figures 5, S7, and S10). In addition, an H/D-exchange
experiment with an exchange time of 1 h of 15-d-old inclusion bodies
of ESAT-6 was measured, which showed no qualitative difference
when compared with freshly prepared inclusion bodies thereof
(unpublished data). Since EM, Thio T, and H/D-exchange measure-
ments of fresh (0 day) and 2-wk-old inclusion bodies show close
resemblance, their integrity over the entire H/D-exchange experi-
ment is assumed. The spectra were analyzed using the programs
PROSA [51] and CARA [52]. At least two independent experiments
were carried out for each protein system.
X-ray diffraction. Pelleted inclusion bodies were resuspended in a
minimal amount of water. Then 5 ll of the suspension were pipetted
between two ﬁre-polished glass rods and left to dry for 2–3 d. The
dried material was placed in an X-ray beam at room temperature for
a 5-min exposure. A rotating anode generator (Rigaku FR-E) and
imaging plate detector (RaxisIVþþ) were used for the data collection.
Two independent experiments were carried out for each protein
system.
SDS-PAGE. After cell lysis and centrifugation, soluble and
insoluble fractions were separated. The insoluble fraction was
resuspended in buffer A in the same amount as the soluble fraction.
To compare the protein amount in each fraction, 5 ll of solution was
taken from either the soluble or the resuspended insoluble fraction,
and was mixed with 10 ll of 10 M UREA and 5 ll of NuPAGE LDS
sample buffer (Invitrogen). Each sample was boiled for 3 min before
loaded to NuPAGE 12% Bis-Tris gel (Invitrogen). Proteins were
visualized by Coomassie Blue staining (0.1% Coomassie Blue, 10%
Figure 5. EM of Inclusion Bodies of BMP2(13–74) with Amyloid-Like
Fibrils upon Incubation
(A) Freshly purified inclusion bodies. They are electron-dense, round
aggregates with a diameter approximately 0.5 lm. In some inclusion
bodies, short amyloid-like fibrils can be observed.
(B) Inclusion bodies after in vitro incubation at 37 8C for 12 h. Fibrils are
present from the purified inclusion bodies.
(C) Freshly purified inclusion bodies from E. coli cells that overexpressed
BMP2(13–74) at 37 8C for 12 h. Fibrils are present from the purified
inclusion bodies.
Scale bars indicate 1 lm.
doi:10.1371/journal.pbio.0060195.g005
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Inclusion Bodies Are Amyloid-Likeacetic acid, 40% methanol). At least two independent experiments
were carried out for each protein system.
To verify the identity of the bands on the SDS gel, that were
present only upon overexpression of wild-type or mutant BMP2(13–
74) fragments, the bands of interest were excised and digested with
trypsin. After digestion, peptides were extracted and analyzed by
matrix-assisted laser desorption/ionization (MALDI)-mass spectrom-
etry (MS). Mass spectrometry was measured on an Applied Biosystems
Voyager DE-STR instrument in linear mode (expected mass accuracy
0.5% or better). Alpha-cyano-hydroxybenzoic acid was used as the
matrix. An average of 100 spectra were summed for each measure-
ment. For both set of bands from inclusion body samples and the
soluble samples, masses corresponding to the expected size of the
wild-type and mutant BMP2(13–74) were observed. Observation of
the masses not only veriﬁed the identity of the bands but also proved
the presence of the mutations.
Circular dichroism. The inclusion body preparation of ESAT-6 was
diluted into buffer A to a ﬁnal concentration of 20 lM. The
experiment was measured on a CD spectrophotometer (BioLogic)
from 200 nm to 260 nm. A 1-mm-thick quartz microcuvette was used.
Electron microscopy. The inclusion body or peptide sample was
diluted into buffer A to a ﬁnal concentration of 50 lM, spotted on a
glow-discharged, carbon-coated Formvar grid (Electron Microscopy
Sciences), incubated for 5 min, washed with distilled water, and then
stained with 1% (w/v) aqueous uranyl formate solution. Uranyl
formate solutions were ﬁltered through 0.2-lm sterile syringe ﬁlters
(Corning) before use. EM analysis was performed using a JEOL JEM-
100CXII electron microscope at 80 kV with nominal magniﬁcation of
48,0003. Images were recorded digitally by using the SIS Megaview III
imaging system. At least two independent experiments were carried
out for each sample.
Peptide ﬁbril formation. Peptides were synthesized either by the
Salk Institute (E20) or Tufts University peptide facility (B13, M11, and
M18) using the solid-phase peptide synthesis approach. Solid peptides
were dissolved in buffer A to a ﬁnal concentration of 500 lM, and the
pH was adjusted to 7.5. The peptide solution was centrifuged at 13
000g for 10 min, and the supernatant was incubated at 37 8C with
stirring for 3 d before observation. The ﬁbril formation was
monitored by EM and Thio T binding.
Supporting Information
Figure S1. Amyloid-Like Properties in Three Bacterial Inclusion
Bodies
CR staining and birefringence of inclusion bodies of BMP2(13–74),
ESAT-6, and MOG(ECD) are indicative of amyloid formation. The
pictures on the left-hand side represent the bright-ﬁeld microscope
images with 103 resolution. The same sections are shown on the
right-hand side under cross-polarized light with 103 magniﬁcation,
respectively.
Found at doi:10.1371/journal.pbio.0060195.sg001 (8.91 MB TIF).
Figure S2. NMR Exchange Curves of ESAT-6, BMP2(13–74), and
MOG(ECD) as Indicated
The evolutions of the peak intensities versus the H/D-exchange time
are shown. Smooth solid lines represent the monoexponential ﬁts of
the raw data after an initial drop of the intensities within the ﬁrst
measurement points. Data for the residues S77 (yellow), K57 (green),
A9 (red), and T23 (cyan) of ESAT-6 are shown. In addition, the
exchange data for residues F41 (yellow), V21 (green), V67 (red), and
I62 (cyan) of BMP2(13–74) are shown. Furthermore, A24 (yellow), G42
(green), A86 (red), and F104 (cyan) of MOG(ECD) are shown. For all
the exchange curves, a biphasic behavior is observed. After an initial
drop of the intensities within the ﬁrst measurement points, a slow
exponential decay is manifested. The relative population P(F) of the
two exchange species is residue-dependent and listed in Figures 2C,
3C, and 4C. The initial drop is attributed to fast H/D exchange
reminiscent of an amorphous structure, whereas the slow exponential
decay is attributed to slow H/D exchange reminiscent of a
homogenous conformational species with hydrogen bond formation.
Found at doi:10.1371/journal.pbio.0060195.sg002 (1.14 MB TIF).
Figure S3. Circular Dichroism of Inclusion Bodies of ESAT-6
Indicative of b-Sheet Conformation
The mean helical ellipticity [h] is shown versus the wavelength of the
light source in nanometers.
Found at doi:10.1371/journal.pbio.0060195.sg003 (613 KB TIF).
Figure S4. Control Experiment for the Mutagenesis of ESAT-6
Coomassie-stained SDS-polyacrylamide gels were obtained from
soluble (s) and insoluble (i) fractions of lysates of E. coli cells
expressing wild-type ESAT-6 constructs that have been back-mutated
from the variants F8R, I11R, I18R, and V22R to wild-type. Since all
back-mutated plasmid constructs show wild-type–like inclusion body
formation, the plasmids of F8R, I11R, I18R, and V22R used in Figure
2E are assumed to be functional. Hence, these controls show that the
amino acid substitution F8R, I11R, I18R, and V22R abolish inclusion
body formation.
Found at doi:10.1371/journal.pbio.0060195.sg004 (125 KB TIF).
Figure S5. Amyloid Fibril Formation of Peptides B13, E20, M11, and
M18
The peptides correspond to the amino acid sequence segments of
BMP2(59–71), ESAT-6(6–25), MOG(85–95), and MOG(101–118) that
are involved in cross-b-sheet structure in inclusion bodies. Upon
incubation of 3 d, all peptides form amyloid ﬁbrils. Transmission EM
was performed of negative-stained, aged peptide samples. Scale bars
indicate 1 lm. The amyloid ﬁbril formation of all peptides were also
conﬁrmed by Thio T binding (unpublished data).
Found at doi:10.1371/journal.pbio.0060195.sg005 (2.25 MB TIF).
Figure S6. Residues 61–70 of BMP(13–74) Move the Otherwise Solubly
Expressed PDZ1 Domain of SAP90 into Inclusion Bodies When Fused
C-Terminally to PDZ1
Coomassie-stained SDS-polyacrylamide gels were obtained from
soluble (s) and insoluble (i) fractions of lysates of E. coli cells
expressing wild-type PDZ1 and a fusion construct, denoted PDZ1-
B10, with residues 61–70 of BMP2 located C-terminally to the PDZ1
domain of SAP90. The 10- and 14-kDa molecular weight standards
are labeled.
Found at doi:10.1371/journal.pbio.0060195.sg006 (1.58 MB TIF).
Figure S7. EM of Inclusion Bodies of ESAT-6 with Amyloid-Like
Fibrils upon Incubation
(A) Freshly puriﬁed inclusion bodies of ESAT-6 are electron-dense,
round aggregates with diameter approximately 0.5 lm.
(B) Inclusion bodies after in vitro incubation at room temperature
(;21 8C) for 14 d. Fibrils are present from the puriﬁed inclusion
bodies.
Scale bars indicate 1 lm.
Found at doi:10.1371/journal.pbio.0060195.sg007 (2.39 MB TIF).
Figure S8. Amyloid-Like Character of Bacterial Inclusion Bodies of
Mouse Prion Protein and Fragments Thereof: PrP(23–231), PrP(90–
231), and PrP(121–231)
CR staining and birefringence under cross-polarized light with 103
magniﬁcation are shown as indicated.
Found at doi:10.1371/journal.pbio.0060195.sg008 (7.93 MB TIF).
Figure S9. The Puriﬁcation Procedures of Inclusion Bodies of ESAT-
6, BMP2(13–74), and MOG(ECD) as Indicated
Coomassie-stained SDS-polyacrylamide gels were obtained from (1) E.
coli cells before induction, (2) E. coli cells after induction, (3) soluble
fraction of the cell lysate, (4) insoluble fraction of the cell lysate, and
(5) puriﬁed inclusion bodies. The molecular weight standards are
labeled under ‘‘M.’’
Found at doi:10.1371/journal.pbio.0060195.sg009 (2.67 MB TIF).
Figure S10. Control Experiments That Show the Preservation of the
Properties of Inclusion Bodies during the H/D-Exchange Experiment
(A) Thio T binding assay before (day 0) and after the H/D-exchange
experiment (day 15) as indicated.
(B) Electron micrograms of the inclusion bodies after the H/D
exchange experiment at day 15 which are similar to fresh inclusion
bodies (Figures 5 and S7). See also Materials and Methods.
Found at doi:10.1371/journal.pbio.0060195.sg010 (872 KB TIF).
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